Literature DB >> 10524633

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.

T A Chan1, H Hermeking, C Lengauer, K W Kinzler, B Vogelstein.   

Abstract

14-3-3Sigma is a member of a family of proteins that regulate cellular activity by binding and sequestering phosphorylated proteins. It has been suggested that 14-3-3sigma promotes pre-mitotic cell-cycle arrest following DNA damage, and that its expression can be controlled by the p53 tumour suppressor gene. Here we describe an improved approach to the generation of human somatic-cell knockouts, which we have used to generate human colorectal cancer cells in which both 14-3-3sigma alleles are inactivated. After DNA damage, these cells initially arrested in the G2 phase of the cell cycle, but, unlike cells containing 14-3-3sigma, the 14-3-3sigma-/- cells were unable to maintain cell-cycle arrest. The 14-3-3sigma-/- cells died ('mitotic catastrophe') as they entered mitosis. This process was associated with a failure of the 14-3-3sigma-deficient cells to sequester the proteins (cyclin B1 and cdc2) that initiate mitosis and prevent them from entering the nucleus. These results may indicate a mechanism for maintaining the G2 checkpoint and preventing mitotic death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524633     DOI: 10.1038/44188

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  217 in total

Review 1.  DNA replication blockade impairs p53-transactivation.

Authors:  R Takimoto; W S El-Deiry
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Establishment of a chemical synthetic lethality screen in cultured human cells.

Authors:  A Simons; N Dafni; I Dotan; Y Oron; D Canaani
Journal:  Genome Res       Date:  2001-02       Impact factor: 9.043

3.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 4.  Anticancer drug targets: cell cycle and checkpoint control.

Authors:  G I Shapiro; J W Harper
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

5.  p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.

Authors:  P M Flatt; L J Tang; C D Scatena; S T Szak; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  The tumour suppressor protein p53 can repress transcription of cyclin B.

Authors:  K Krause; M Wasner; W Reinhard; U Haugwitz; C L Dohna; J Mössner; K Engeland
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

Review 7.  Cell cycle checkpoints and their inactivation in human cancer.

Authors:  M Molinari
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

8.  Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.

Authors:  Hui Tian; Alexander T Faje; Siu Lan Lee; Timothy J Jorgensen
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

9.  Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability.

Authors:  S Dhar; J A Squire; M P Hande; R J Wellinger; T K Pandita
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

10.  The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.

Authors:  Matthew D Westfall; Deborah J Mays; Joseph C Sniezek; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.